Scholarlink

Background <p>Understanding patients’ symptom recovery after upper gastrointestinal (UGI) cancer surgery is essential for patient-centered care, yet detailed longitudinal patient-reported outcome data remain limited. We conducted a prospective study using the novel MD Anderson Symptom Inventory for UGI Surgery (MDASI-UGI-Surg) tool.</p> Methods <p>Patients undergoing esophageal (<i>n</i> = 42), gastric (<i>n</i> = 27), or pancreatic (<i>n</i> = 74) cancer surgery from February to September 2024 were enrolled. The MDASI-UGI-Surg comprises 22 symptoms and 6 interference items. The five most severe symptoms and three most severe interference items on postoperative day (POD) 3 were identified. Recovery was defined as achieving mild severity for both symptom and interference composites. Multivariable analysis was performed to identify factors associated with recovery at postoperative month (POM) 1.</p> Results <p>Most symptoms peaked at POD3. The five most severe symptoms were pain, fatigue, sleep disturbance, drowsiness, and dry mouth; the top three interference items were general activity, working, and enjoyment of life. Symptom recovery followed three phases: an acute improvement phase (POD3–14), a plateau phase (POD14–POM1), and a persistent recovery phase extending to POM6. Symptom profiles were similar across organ groups, and fatigue remained prolonged. Cumulative recovery rates were 64.8% at POM1, 78.9% at POM3, and 90.8% at POM6. Postoperative complications and readmissions were associated with delayed recovery at POM1, and the type of surgery predicted recovery in multivariable models.</p> Conclusions <p>This study provides a detailed characterization of symptom recovery after UGI cancer surgery. These findings support improved preoperative counseling and postoperative care planning.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Patient-Reported Symptom Recovery After Upper Gastrointestinal Cancer Surgery: A Prospective Study Using the MDASI-UGI-Surg

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月19日

查看全文
  • Koichi Tomita,
  • Paula M. Smith,
  • Maho Takayama,
  • Cong Pan,
  • Shu-En Shen,
  • Xuemei Wang,
  • Xin Shelley Wang,
  • Loretta A. Williams,
  • Elsa M. Arvide,
  • Connie To,
  • Ravi Rajaram,
  • Kyle G. Mitchell,
  • David C. Rice,
  • Wayne L. Hofstetter,
  • Mara B. Antonoff,
  • Reza J. Mehran,
  • Ara J. Vaporciyan,
  • Garrett L. Walsh,
  • Jessica E. Maxwell,
  • Rebecca A. Snyder,
  • Michael P. Kim,
  • Ching-Wei D. Tzeng,
  • Paul F. Mansfield,
  • Stephen G. Swisher,
  • Jeffrey E. Lee,
  • Brian D. Badgwell,
  • Matthew H. G. Katz,
  • Naruhiko Ikoma

摘要

Background

Understanding patients’ symptom recovery after upper gastrointestinal (UGI) cancer surgery is essential for patient-centered care, yet detailed longitudinal patient-reported outcome data remain limited. We conducted a prospective study using the novel MD Anderson Symptom Inventory for UGI Surgery (MDASI-UGI-Surg) tool.

Methods

Patients undergoing esophageal (n = 42), gastric (n = 27), or pancreatic (n = 74) cancer surgery from February to September 2024 were enrolled. The MDASI-UGI-Surg comprises 22 symptoms and 6 interference items. The five most severe symptoms and three most severe interference items on postoperative day (POD) 3 were identified. Recovery was defined as achieving mild severity for both symptom and interference composites. Multivariable analysis was performed to identify factors associated with recovery at postoperative month (POM) 1.

Results

Most symptoms peaked at POD3. The five most severe symptoms were pain, fatigue, sleep disturbance, drowsiness, and dry mouth; the top three interference items were general activity, working, and enjoyment of life. Symptom recovery followed three phases: an acute improvement phase (POD3–14), a plateau phase (POD14–POM1), and a persistent recovery phase extending to POM6. Symptom profiles were similar across organ groups, and fatigue remained prolonged. Cumulative recovery rates were 64.8% at POM1, 78.9% at POM3, and 90.8% at POM6. Postoperative complications and readmissions were associated with delayed recovery at POM1, and the type of surgery predicted recovery in multivariable models.

Conclusions

This study provides a detailed characterization of symptom recovery after UGI cancer surgery. These findings support improved preoperative counseling and postoperative care planning.